Regulus Therapeutics Reports First Quarter 2021 Financial Results and Recent Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. PLTR
4. LITE
5. REGN
6. ABBV
7. MRVL
8. CL
9. CHKP
10. LYB

Go back to Regulus Therapeutics Reports First Quarter 2021 Financial Results and Recent Updates

Regulus Therapeutics (RGLS) Tops Q1 EPS by 1c

May 13, 2021 4:24 PM EDT

Regulus Therapeutics (NASDAQ: RGLS) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09).

"We are excited about the data we recently announced from the first cohort of our phase 1b clinical trial of RGLS4326 for the treatment of patients with ADPKD... More